Suppr超能文献

患者和家属在镰状细胞病疼痛管理中的阿片类药物决策:一项定性研究。

Patient and Family Opioid Decision-Making for Pain Management in Sickle Cell Disease: A Qualitative Study.

机构信息

College of Nursing, Medical University of South Carolina, Charleston, South Carolina.

Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.

出版信息

J Pain. 2023 Jul;24(7):1240-1250. doi: 10.1016/j.jpain.2023.02.022. Epub 2023 Feb 28.

Abstract

Pain is a significant symptom experienced frequently by individuals with sickle cell disease (SCD). Pain management includes strategies such as oral rehydration, non-pharmacological therapies (eg, massage, relaxation), and oral analgesics and opioids. Shared decision-making around pain management is emphasized repeatedly in recent guidelines; however, research is sparse regarding factors to be considered in shared decision-making approaches including the perceived risks and benefits of opioids. This qualitative descriptive study was conducted to explore perspectives of decision-making for opioid medications in SCD. We conducted 20 in-depth interviews with caregivers of children with SCD and individuals with SCD to elucidate the decision-making processes around home use of opioid therapy for pain management at a single center. Themes were identified in the domains of the Decision Problem (Alternatives and Choices; Outcomes and Consequences; Complexity), the Context (Multilevel Stressors and Supports; Information; Patient-Provider Interactions), and the Patient (Decision-Making Approaches; Developmental Status; Personal and Life Values; Psychological State). Key findings indicated opioid management for pain in SCD is important yet complex and requires collaboration among patients, families, and providers. Elements of patient and caregiver decision-making identified in this study may be applied to shared decision-making strategies in the clinical setting and future study. PERSPECTIVE: This study illustrates the factors involved in decision-making around home opioid use for pain management in children and young adults with SCD. These findings can be applied to determining shared decision-making approaches around pain management between providers and patients, in accordance with recent SCD pain management guidelines.

摘要

疼痛是镰状细胞病(SCD)患者经常经历的一种严重症状。疼痛管理包括口服补液、非药物治疗(如按摩、放松)和口服镇痛药和阿片类药物等策略。最近的指南反复强调了疼痛管理中的共同决策,但关于共同决策方法中要考虑的因素(包括阿片类药物的感知风险和益处)的研究很少。这项定性描述性研究旨在探讨 SCD 中阿片类药物决策的观点。我们在一家中心对儿童 SCD 照顾者和 SCD 患者进行了 20 次深入访谈,以阐明家庭使用阿片类药物治疗疼痛管理的决策过程。在决策问题(替代方案和选择;结果和后果;复杂性)、背景(多层次压力源和支持;信息;医患互动)和患者(决策方法;发展状况;个人和生活价值观;心理状态)领域确定了主题。主要发现表明,SCD 中的疼痛管理虽然重要但很复杂,需要患者、家庭和提供者之间的合作。本研究中确定的患者和照顾者决策因素可应用于临床实践中的共同决策策略和未来的研究。观点:本研究说明了在 SCD 儿童和年轻人中,家庭使用阿片类药物治疗疼痛管理的决策中涉及的因素。这些发现可用于根据最近的 SCD 疼痛管理指南确定提供者和患者之间的疼痛管理共同决策方法。

相似文献

1
Patient and Family Opioid Decision-Making for Pain Management in Sickle Cell Disease: A Qualitative Study.
J Pain. 2023 Jul;24(7):1240-1250. doi: 10.1016/j.jpain.2023.02.022. Epub 2023 Feb 28.
2
Sickle cell disease patients with and without extremely high hospital use: pain, opioids, and coping.
J Pain Symptom Manage. 2015 Mar;49(3):539-47. doi: 10.1016/j.jpainsymman.2014.06.007. Epub 2014 Jul 22.
6
Psychosocial and pharmacological management of pain in pediatric sickle cell disease.
Postgrad Med. 2014 Mar;126(2):123-33. doi: 10.3810/pgm.2014.03.2748.
7
Daily home opioid use in adults with sickle cell disease: The PiSCES project.
J Opioid Manag. 2015 May-Jun;11(3):243-53. doi: 10.5055/jom.2015.0273.
8
Comprehensive, integrative management of pain for patients with sickle-cell disease.
J Altern Complement Med. 2006 Dec;12(10):995-1001. doi: 10.1089/acm.2006.12.995.
10
Disease-modifying therapies for sickle cell disease: Decisional needs and supports among adolescents and young adults.
Pediatr Blood Cancer. 2024 Jul;71(7):e30999. doi: 10.1002/pbc.30999. Epub 2024 Apr 15.

引用本文的文献

1
A Pilot Assessment of Caregivers' and Patients' Perception of Naloxone Coprescribing in a Pediatric Sickle Cell Population.
J Pediatr Pharmacol Ther. 2025 Aug;30(4):498-503. doi: 10.5863/JPPT-24-00071. Epub 2025 Aug 11.
2
Investigating home-based opioid use among youth with sickle cell disease using ecological momentary assessment.
Pediatr Blood Cancer. 2024 Aug;71(8):e31116. doi: 10.1002/pbc.31116. Epub 2024 May 27.
3
Prescription Opioid Decision-making and Use Behaviors in Adolescents With Acute Pain: A Qualitative Study.
Clin J Pain. 2024 Jun 1;40(6):333-340. doi: 10.1097/AJP.0000000000001205.

本文引用的文献

1
Shared Decision-Making in Managing Breakthrough Cancer Pain in Patients With Advanced Cancer.
J Adv Pract Oncol. 2022 Jan;13(1):19-29. doi: 10.6004/jadpro.2022.13.1.2. Epub 2022 Feb 1.
3
Patient Perspectives of Sickle Cell Management in the Emergency Department.
Crit Care Nurs Q. 2021;44(2):160-174. doi: 10.1097/CNQ.0000000000000350.
4
American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.
Blood Adv. 2020 Jun 23;4(12):2656-2701. doi: 10.1182/bloodadvances.2020001851.
5
6
Reducing Health Care Disparities in Sickle Cell Disease: A Review.
Public Health Rep. 2019 Nov/Dec;134(6):599-607. doi: 10.1177/0033354919881438. Epub 2019 Oct 10.
7
Opioid treatment for acute and chronic pain in patients with sickle cell disease.
Neurosci Lett. 2020 Jan 1;714:134534. doi: 10.1016/j.neulet.2019.134534. Epub 2019 Oct 5.
10
A Qualitative Study of Chronic Pain and Self-Management in Adults with Sickle Cell Disease.
J Natl Med Assoc. 2019 Apr;111(2):158-168. doi: 10.1016/j.jnma.2018.08.001. Epub 2018 Sep 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验